Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Published Online: 2011-04-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Augustin Ferrant•Drew J Winston•Francisco M Marty•Genovefa A Papanicolaou•Hermann Einsele•Hongzi Chen•Jeffrey H Lipton•Jo-Anne H Young•Johan Maertens•Lynne Strasfeld•Michael Boeckh•Michael Schmitt•Per Ljungman•Roy F Chemaly•Stephen A Villano•Tulio Rodriguez
